Privia Health Group, Inc. carries a market capitalization of 2.60B, placing it among publicly traded companies globally. Its enterprise value stands at 2.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.60B |
| Enterprise Value | 2.17B |
Privia Health Group, Inc. currently has 125.69M shares outstanding.
| Shares Outstanding | 125.69M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Privia Health Group, Inc. trades at a trailing price-to-earnings ratio of 116.31. The price-to-sales ratio is 1.13, and the price-to-book ratio stands at -16.65.
| PE Ratio | 116.31 |
| PS Ratio | 1.13 |
| PB Ratio | -16.65 |
| P/TBV Ratio | 6.60 |
| P/FCF Ratio | 19.32 |
| P/OCF Ratio | 18.34 |
On an enterprise value basis, Privia Health Group, Inc. trades at an EV/EBITDA multiple of 45.55 and an EV/FCF ratio of 15.75. The EV/Sales ratio of 0.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 59.65 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.97 |
| EV / EBITDA | 45.55 |
| EV / EBIT | 59.65 |
| EV / FCF | 15.75 |
Privia Health Group, Inc. maintains a current ratio of 1.61, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.61 |
| Quick Ratio | 1.55 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 0.19 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 1.67 |
| Return on Invested Capital (ROIC) | 2.89 |
| Return on Capital Employed (ROCE) | -15.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Privia Health Group, Inc. has paid 17.71M in income taxes, reflecting an effective tax rate of 39.27.
| Income Tax | 17.71M |
| Effective Tax Rate | 39.27 |
Privia Health Group, Inc.'s stock has declined approximately -10.0566% over the past 52 weeks. The 50-day moving average sits at 22.73, while the 200-day moving average is 23.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.0566% |
| 50-Day Moving Average | 22.73 |
| 200-Day Moving Average | 23.25 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Privia Health Group, Inc. generated 2.25B in revenue and converted that into 21.76M in net income, yielding earnings per share of 0.21. EBITDA reached 47.73M, while operating income came in at 36.44M.
| Revenue | 2.25B |
| Gross Profit | 223.98M |
| Operating Income | 36.44M |
| Pretax Income | 45.10M |
| Net Income | 21.76M |
| EBITDA | 47.73M |
| EBIT | 36.44M |
| Earnings Per Share (EPS) | 0.21 |
Privia Health Group, Inc. holds 419.52M in cash and equivalents against 9.02M in total debt, resulting in a net debt position of -419.52M. Total book value stands at -151.99M, with working capital of 364.72M providing operational flexibility.
| Cash & Cash Equivalents | 419.52M |
| Total Debt | 9.02M |
| Net Debt | -419.52M |
| Equity (Book Value) | -151.99M |
| Book Value Per Share | -1.24 |
| Working Capital | 364.72M |
Privia Health Group, Inc. produced 138.00M in operating cash flow over the past twelve months.
| Operating Cash Flow | 138.00M |
| Capital Expenditures | N/A |
| Free Cash Flow | 138.00M |
| FCF Per Share | 1.12 |
Privia Health Group, Inc. operates with a gross margin of 9.97, reflecting its pricing power and cost economics. The operating margin of 1.62 and net profit margin of 0.97 provide insight into operational efficiency.
| Gross Margin | 9.97 |
| Operating Margin | 1.62 |
| Pretax Margin | 2.01 |
| Profit Margin | 0.97 |
| EBITDA Margin | 2.12 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.25 |
| FCF Yield | 5.18 |
Privia Health Group, Inc. posts an Altman Z-Score of 5.08, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.08 |